UNSPSC 41202028: Gonococcal antibody test (gat)

In this classification, Gonococcal antibody test (gat) are devices used in test to identify specific Gonococcal antibody test (gat) antibodies in serum. US FDA regulates Gonococcal antibody test (gat) under 21 CFR 866.3290 and under FDA product code LGB.

UNSPSC 41202028 Gonococcal antibody test (gat) is a Commodity code that maps poorly to the recent state and local solicitation activity in the source. The code's nominal scope—rapid or laboratory-based gonococcal antibody detection—does not align with the opportunities posted under this designation. The recent solicitations cluster around HIV and Syphilis testing (reagents, kits, screening assays, and laboratory services), along with one unrelated forensic analysis opportunity and one pool maintenance bid; none explicitly names gonococcal antibody testing as a deliverable. State and local buyers using this code appear to be health departments (Illinois Department of Public Health, City of Austin Public Health), criminal justice agencies (Collin County Community Supervision and Corrections Department, Texas Department of Criminal Justice), and one university health center (University of Houston Student Health Center). When gonococcal testing is procured by state and local bodies, it is typically bundled within broader STI or multiplex screening programs rather than solicited as a standalone commodity.

Recent activity shows a geographic concentration in Texas and Illinois. The most active recent solicitation is Collin County's RFP 2026-327 for Offender Specimen Collection and Drug Testing Services (due July 23, 2026), which encompasses immunoassay screening and confirmation testing across multiple analytes at two collection sites with an estimated annual volume of 25,031 tests and a $600,000 contract value over two years with optional renewals through 2031. The Illinois Department of Public Health issued an IFB (26482DPHOFCDIB50489, due March 16, 2026) for a five-year contract with automated combination screening for HIV, Syphilis, and Hepatitis B and C across approximately 13,200 HIV and 11,000 Syphilis tests annually; IDPH also conducted emergency sole-source procurements to Abbott Laboratories for HIV and Syphilis reagents ($38,079.50, executed February–May 2026). The City of Austin posted an IFB (IFB9100AAM1023, due July 17, 2026) for rapid HIV test kits to support the Public Health Program. The source shows no recent competitive opportunities explicitly for gonococcal antibody testing as a distinct line item, suggesting the code may be a secondary or misapplied tag in state and local procurement systems.